Triiodothyronine response to thyrotrophin releasing hormone in patients with hypothalamic-pituitary disorders

Clin Endocrinol (Oxf). 1975 Nov;4(6):585-90. doi: 10.1111/j.1365-2265.1975.tb01927.x.

Abstract

The serum triiodothyronine concentration was evaluated before and after thyrotrophin releasing hormone in fifty-six patients with hypothalamic-pituitary disorders (thirty-four had secondary hypothyroidism, twenty-two were euthyroid) and in twenty-four normal controls. Basal serum T3 was low in fifteen hypothyroid subjects and normal in the remainders. After TRH, serum T3 did not increase normally in twenty-five hypothyroid and in ten euthyroid patients; even the patients with normal or supranormal plasma TSH increase had significantly lower T3 responses than normal controls (P less than 0-0001 for hypothyroid, P less than 0-01 for euthyroid subjects). The finding of low T3 response to TRH in some euthyroid patients with hypothalamic-pituitary disorders can perhaps identify cases of preclinical secondary hypothyroidism, probably due to low biological activity of released TSH.

Publication types

  • Clinical Trial

MeSH terms

  • Clinical Trials as Topic
  • Female
  • Humans
  • Hypothyroidism / blood*
  • Male
  • Pituitary Diseases / blood*
  • Thyrotropin / blood
  • Thyrotropin-Releasing Hormone / pharmacology*
  • Triiodothyronine / blood*

Substances

  • Triiodothyronine
  • Thyrotropin-Releasing Hormone
  • Thyrotropin